Pharmaceutical Technology5 小时
Volrustomig by AstraZeneca for Malignant Neoplasms: Likelihood of Approval
Volrustomig is under clinical development by AstraZeneca and currently in Phase II for Malignant Neoplasms. According to GlobalData, Phase II drugs for Malignant Neoplasms does not have sufficient ...
Pharmaceutical Technology5 小时
GEN-1184 by Genmab for Malignant Mesothelioma: Likelihood of Approval
GEN-1184 is under clinical development by Genmab and currently in Phase II for Malignant Mesothelioma. According to GlobalData, Phase II drugs for Malignant Mesothelioma have a 42% phase transition ...
Nigerian Tribune19 小时
Doctor catches cancer from patient in first-of-a-kind case
A doctor operating on a cancer patient accidentally ‘transplanted’ the disease into himself in what is believed to be a ...